Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.
about
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@en
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@nl
type
label
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@en
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@nl
prefLabel
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@en
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@nl
P2093
P2860
P1433
P1476
Autoantibodies against oncogen ...... h C-MYC, AMACR and HERV-K Gag.
@en
P2093
Ahmed A Mohamed
Alagarsamy Srinivasan
Albert Dobi
Anshu Rastogi
Charles P Xavier
David G McLeod
Denise Young
Inger L Rosner
Isabell A Sesterhenn
P2860
P304
P356
10.18632/GENESANDCANCER.126
P577
2016-11-01T00:00:00Z